Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurometabolic Disorders industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Protalix BioTherapeutics
UAB Proforma
Neuraltus Pharmaceuticals
Amicus
Biosidus
Biomarin
Amicus Therapeutics
Shire
Greencross
Dong-A Socio Group
Lixte Biotechnology
ExSAR Corporation
Greenovation Biotech
ISU Abxis
Pharming Group
By Type:
Gaucher’s Disease
Pompe Disease
Fabry Disease
Other
Mucopolysaccharidosis VI
By Application:
Oral
Parenteral
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurometabolic Disorders Market Overview 2018-2029
-
1.1 China Neurometabolic Disorders Industry Development Overview
-
1.2 China Neurometabolic Disorders Industry Development History
-
1.3 China Neurometabolic Disorders Industry Market Size (2018-2029)
-
1.4 China Neurometabolic Disorders Market Analysis by Type from Production Side
-
1.4.1 China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Gaucher’s Disease (2018-2029)
-
1.4.2 China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Pompe Disease (2018-2029)
-
1.4.3 China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Fabry Disease (2018-2029)
-
1.4.4 China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.5 China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Mucopolysaccharidosis VI (2018-2029)
-
1.5 China Neurometabolic Disorders Market Analysis by Application from Consumption End
-
1.5.1 China Neurometabolic Disorders Sales Volume, Sales Value and Growth Rate of Oral (2018-2029)
-
1.5.2 China Neurometabolic Disorders Sales Volume, Sales Value and Growth Rate of Parenteral (2018-2029)
-
1.6 China Neurometabolic Disorders Market Analysis by Region
-
1.6.1 North China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurometabolic Disorders Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurometabolic Disorders Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurometabolic Disorders Market Status and Competition Analysis in 2023
-
2.2.3 China Neurometabolic Disorders Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurometabolic Disorders Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurometabolic Disorders Industry Development
Chapter 3 Neurometabolic DisordersIndustry Chain Analysis
-
3.1 Neurometabolic Disorders Industry Chain
-
3.2 Neurometabolic Disorders Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurometabolic Disorders Market
-
3.3 Neurometabolic Disorders Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurometabolic Disorders Market
Chapter 4 China Neurometabolic Disorders Market, by Type
-
4.1 China Neurometabolic Disorders Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurometabolic Disorders Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurometabolic Disorders Production Volume and Growth Rate, by Type
-
4.5.1 China Neurometabolic Disorders Production Volume and Growth Rate of Gaucher’s Disease
-
4.5.2 China Neurometabolic Disorders Production Volume and Growth Rate of Pompe Disease
-
4.5.3 China Neurometabolic Disorders Production Volume and Growth Rate of Fabry Disease
-
4.5.4 China Neurometabolic Disorders Production Volume and Growth Rate of Other
-
4.5.5 China Neurometabolic Disorders Production Volume and Growth Rate of Mucopolysaccharidosis VI
Chapter 5 China Neurometabolic Disorders Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurometabolic Disorders Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurometabolic Disorders Market Size and Growth Rate, by Application
-
5.5.1 China Neurometabolic Disorders Market Size and Growth Rate of Oral
-
5.5.2 China Neurometabolic Disorders Market Size and Growth Rate of Parenteral
Chapter 6 China Neurometabolic Disorders Market, by Region
-
6.1 China Neurometabolic Disorders Production Volume and Production Value, by Region
-
6.2 China Neurometabolic Disorders Sales Volume and Sales Value, by Region
Chapter 7 North China Neurometabolic Disorders Market Analysis
-
7.1 North China Neurometabolic Disorders Market, by Type
-
7.2 North China Neurometabolic Disorders Market, by Application
Chapter 8 Central China Neurometabolic Disorders Market Analysis
-
8.1 Central China Neurometabolic Disorders Market, by Type
-
8.2 Central China Neurometabolic Disorders Market, by Application
Chapter 9 South China Neurometabolic Disorders Market Analysis
-
9.1 South China Neurometabolic Disorders Market, by Type
-
9.2 South China Neurometabolic Disorders Market, by Application
Chapter 10 East China Neurometabolic Disorders Market Analysis
-
10.1 East China Neurometabolic Disorders Market, by Type
-
10.2 East China Neurometabolic Disorders Market, by Application
Chapter 11 Northeast China Neurometabolic Disorders Market Analysis
-
11.1 Northeast China Neurometabolic Disorders Market, by Type
-
11.2 Northeast China Neurometabolic Disorders Market, by Application
Chapter 12 Southwest China Neurometabolic Disorders Market Analysis
-
12.1 Southwest China Neurometabolic Disorders Market, by Type
-
12.2 Southwest China Neurometabolic Disorders Market, by Application
Chapter 13 Northwest China Neurometabolic Disorders Market Analysis
-
13.1 Northwest China Neurometabolic Disorders Market, by Type
-
13.2 Northwest China Neurometabolic Disorders Market, by Application
Chapter 14 Company Profiles
-
14.1 Protalix BioTherapeutics
-
14.1.1 Protalix BioTherapeutics Company Profile
-
14.1.2 Protalix BioTherapeutics Neurometabolic Disorders Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 UAB Proforma
-
14.2.1 UAB Proforma Company Profile
-
14.2.2 UAB Proforma Neurometabolic Disorders Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Neuraltus Pharmaceuticals
-
14.3.1 Neuraltus Pharmaceuticals Company Profile
-
14.3.2 Neuraltus Pharmaceuticals Neurometabolic Disorders Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amicus
-
14.4.1 Amicus Company Profile
-
14.4.2 Amicus Neurometabolic Disorders Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biosidus
-
14.5.1 Biosidus Company Profile
-
14.5.2 Biosidus Neurometabolic Disorders Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Biomarin
-
14.6.1 Biomarin Company Profile
-
14.6.2 Biomarin Neurometabolic Disorders Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amicus Therapeutics
-
14.7.1 Amicus Therapeutics Company Profile
-
14.7.2 Amicus Therapeutics Neurometabolic Disorders Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Shire
-
14.8.1 Shire Company Profile
-
14.8.2 Shire Neurometabolic Disorders Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Greencross
-
14.9.1 Greencross Company Profile
-
14.9.2 Greencross Neurometabolic Disorders Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Dong-A Socio Group
-
14.10.1 Dong-A Socio Group Company Profile
-
14.10.2 Dong-A Socio Group Neurometabolic Disorders Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Lixte Biotechnology
-
14.11.1 Lixte Biotechnology Company Profile
-
14.11.2 Lixte Biotechnology Neurometabolic Disorders Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 ExSAR Corporation
-
14.12.1 ExSAR Corporation Company Profile
-
14.12.2 ExSAR Corporation Neurometabolic Disorders Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Greenovation Biotech
-
14.13.1 Greenovation Biotech Company Profile
-
14.13.2 Greenovation Biotech Neurometabolic Disorders Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 ISU Abxis
-
14.14.1 ISU Abxis Company Profile
-
14.14.2 ISU Abxis Neurometabolic Disorders Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Pharming Group
-
14.15.1 Pharming Group Company Profile
-
14.15.2 Pharming Group Neurometabolic Disorders Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurometabolic Disorders Industry Research Conclusions
-
15.2 Neurometabolic Disorders Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurometabolic Disorders Industry Market Size (2018-2029)
-
Figure China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Gaucher’s Disease (2018-2029)
-
Figure China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Pompe Disease (2018-2029)
-
Figure China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Fabry Disease (2018-2029)
-
Figure China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Neurometabolic Disorders Production Volume, Production Value and Growth Rate of Mucopolysaccharidosis VI (2018-2029)
-
Figure China Neurometabolic Disorders Sales Volume, Sales Value and Growth Rate of Oral (2018-2029)
-
Figure China Neurometabolic Disorders Sales Volume, Sales Value and Growth Rate of Parenteral (2018-2029)
-
Figure North China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure South China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure East China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurometabolic Disorders Market Size and Growth Rate from 2018-2029
-
Figure Neurometabolic Disorders Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurometabolic Disorders Market Share by Type in 2018
-
Figure China Neurometabolic Disorders Market Share by Type in 2023
-
Figure China Neurometabolic Disorders Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume and Growth Rate of Gaucher’s Disease (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume and Growth Rate of Pompe Disease (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume and Growth Rate of Fabry Disease (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume and Growth Rate of Mucopolysaccharidosis VI (2018-2023)
-
Figure China Neurometabolic Disorders Market Share by Application in 2018
-
Figure China Neurometabolic Disorders Market Share by Application in 2023
-
Figure China Neurometabolic Disorders Total Market Size and Growth Rate from Consumption End
-
Figure China Neurometabolic Disorders Market Size and Growth Rate of Oral (2018-2023)
-
Figure China Neurometabolic Disorders Market Size and Growth Rate of Parenteral (2018-2023)
-
Table China Neurometabolic Disorders Production Volume by Region (2018-2023)
-
Table China Neurometabolic Disorders Production Volume Share by Region (2018-2023)
-
Figure China Neurometabolic Disorders Production Volume Share by Region (2018-2023)
-
Table China Neurometabolic Disorders Production Value by Region (2018-2023)
-
Table China Neurometabolic Disorders Production Value Share by Region (2018-2023)
-
Figure China Neurometabolic Disorders Production Value Share by Region (2018-2023)
-
Table China Neurometabolic Disorders Sales Volume by Region (2018-2023)
-
Table China Neurometabolic Disorders Sales Volume Share by Region (2018-2023)
-
Figure China Neurometabolic Disorders Sales Volume Share by Region (2018-2023)
-
Table China Neurometabolic Disorders Sales Value by Region (2018-2023)
-
Table China Neurometabolic Disorders Sales Value Share by Region (2018-2023)
-
Figure China Neurometabolic Disorders Sales Value Share by Region (2018-2023)
-
Table North China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table North China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure North China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table North China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table North China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure North China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table Central China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table Central China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure Central China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table Central China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table Central China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table South China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table South China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure South China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table South China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table South China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure South China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table East China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table East China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure East China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table East China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table East China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure East China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table Northeast China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table Northeast China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table Southwest China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table Southwest China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurometabolic Disorders Production Volume by Type (2018-2023)
-
Table Northwest China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurometabolic Disorders Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurometabolic Disorders Sales Volume by Application (2018-2023)
-
Table Northwest China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurometabolic Disorders Sales Volume Share by Application (2018-2023)
-
Table Protalix BioTherapeutics Company Profile
-
Table Protalix BioTherapeutics Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table UAB Proforma Company Profile
-
Table UAB Proforma Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Neuraltus Pharmaceuticals Company Profile
-
Table Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Amicus Company Profile
-
Table Amicus Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Biosidus Company Profile
-
Table Biosidus Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Biomarin Company Profile
-
Table Biomarin Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Amicus Therapeutics Company Profile
-
Table Amicus Therapeutics Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Greencross Company Profile
-
Table Greencross Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Dong-A Socio Group Company Profile
-
Table Dong-A Socio Group Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Lixte Biotechnology Company Profile
-
Table Lixte Biotechnology Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table ExSAR Corporation Company Profile
-
Table ExSAR Corporation Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Greenovation Biotech Company Profile
-
Table Greenovation Biotech Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table ISU Abxis Company Profile
-
Table ISU Abxis Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
Table Pharming Group Company Profile
-
Table Pharming Group Neurometabolic Disorders Revenue, Price and Gross (2018-2023)
-
